TheNewswire - March 2, 2023 - Molecule Holdings Inc. (CSE:MLCL) (“Molecule” or the “Company”), a Canadian craft-focused cannabis beverage production company, today announces that, further to its press release on February 10, 2023 and February 28, 2023 (together, the “Default Announcement”), on March 1, 2023, the Ontario Securities Commission (the “OSC”), as the Company’s principal regulator, granted the Company’s previously-announced application for the issue of a management cease trade order (the “MCTO”) under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).

The Company has been delayed in filing its annual financial statements (the “2022 Annual Financial Statements”), management’s discussion and analysis and related officer certifications for the financial year ended October 31, 2022 (collectively, the “Annual Filings”). As previously announced, the Company applied for the MCTO as a result of the Company having had unpaid audit fees with respect to the audit for the financial year ended October 31, 2021. The unpaid amounts with respect to the previous year’s audit fees delayed the beginning of the audit process for the 2022 Annual Financial Statements, however, the unpaid amounts have since been paid and the audit process for the 2022 Annual Financial Statements has now begun with the Company’s auditors.

The Company is working closely with its auditor and expects to file the Annual Filings as soon as possible, and in any event no later than April 28, 2023 (the “Filing Deadline”).

During  the  MCTO,  investors will  continue  to  be  able  to  trade  in  common shares in the capital of the Company (the “Common Shares”) listed on the Canadian Securities Exchange (the “CSE”). However, the Company’s Chief Executive Officer and Chief Financial Officer and such other directors, officers and persons as determined by the applicable  regulatory  authorities  will  not  be  able  to  trade  in  the  Common Shares,  nor  will  the  Company be able to, directly or indirectly, issue securities to or acquire securities from an insider or employee  of  the  Company  until  such  time  as  the  Annual  Filings  and  all  continuous  disclosure  requirements have been filed by the Company, and the MCTO has been lifted.

Until the Company files its Annual Filings, it intends to comply with the alternative information guidelines set  out  in  NP  12-203, including the issuance of bi-weekly default status reports in the form of news releases, for as long as the Company remains in default.

The Company confirms as of the date of this news release that there have been no changes to the information contained in the Default Announcement, there is no insolvency proceeding against it, and other material information concerning the affairs of the Company that has not been generally disclosed. As required under Canadian securities laws, the Company will provide a further update on or about March 16, 2023.

For further information, please contact:

André Audet, Chairman and Co-Founder

Phone: 1 (888) 665-2853 x101

Email: andre@molecule.ca

www.molecule.ca

About Molecule Holdings Inc.

Molecule is a licensed producer dedicated to creating cannabis-infused beverages for the Canadian market. We produce leading, top-quality drinks to provide opportunity and choice to people seeking a convenient and social way to consume cannabis. Molecule is focused on growing both our portfolio, and the overall cannabis beverage market. We want to ensure people have the best opportunity to find exactly the product and experience they thirst for.

Neither the CSE nor its regulation services provider accepts responsibility for the adequacy or accuracy of this press release.

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that constitute “forward-looking information” (“forward-looking information”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking information and are based on expectations, estimates and projections as at the date of this news release. Any statement that discusses predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking information. In disclosing the forward-looking information contained in this press release, the Company has made certain assumptions. Forward-looking information in this press release include statements related to the Company’s ability to complete the audit and file the Annual Filings; the timing for completion and filing of the Annual Filings, if at all; the Company’s ability to comply with the provisions set out in NP 12-203; and the Company’s ability to produce cannabis-infused beverages for the Canadian beverage market to provide opportunities for people to consume cannabis. In disclosing the forward-looking information contained in this press release, the Company has made certain assumptions.

The Company’s actual results could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which the Company operates, prevailing economic conditions, and other factors, many of which are beyond the control of the Company. Specifically, there are risks that: the Annual Filings may not be completed on the terms and timing described herein or at all; or the Company does not comply with the provisions set out in NP 12-203. Additional risk factors can also be found in the Company’s current MD&A, which has been filed on SEDAR and can be accessed at www.sedar.com.

The Company believes that the expectations reflected in the forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward-looking information contained in this news release represents the Company’s expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.

52285937.1